Connecting through the chaos – why medical affairs needs creative problem-solving
By Ali Walsh
Read More
Section: Marketing
GC Therapeutics appoints Kate Haviland as Board Chair
Haviland was most recently President and CEO of Blueprint Medicines
Read More
AstraZeneca announces $15bn investment in Chinese manufacturing and R&D by 2030
The pharma company will be the first global biopharma with end-to-end cell therapy capabilities in China
Read More
Ipsen appoints Pierrick Lefranc as Executive Vice President Technical Operations
Lefranc has served at Ipsen since 2013, most recently as Senior Vice President
Read More
Emotive appoints Terri Cooper as chair of the board and Mark Swindell as non-executive director
Terri and Mark both have extensive life sciences and consulting experience
Read More